Gene · 4205
Papers4,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Control of Muscle Stem Cells: Focus on Histone Lysine Demethylases. | Front Cell Dev Biol | 2022 | 35669509 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics-Based Study of Transcriptional Regulatory Features in the Non-Obstructive Azoospermia Testis. | Front Genet | 2022 | 35669193 | PubTator, text mining | PubMed |
| Reduction of Drosophila Mitochondrial RNase P in Skeletal and Heart Muscle Causes Muscle Degeneration, Cardiomyopathy, and Heart Arrhythmia. | Front Cell Dev Biol | 2022 | 35663400 | PubTator, text mining | PubMed |
| Venus: Elucidating the Impact of Amino Acid Variants on Protein Function Beyond Structure Destabilisation. | J Mol Biol | 2022 | 35662467 | PubTator, text mining | PubMed |
| GRM1 Immunohistochemistry Distinguishes Chondromyxoid Fibroma From its Histologic Mimics. | Am J Surg Pathol | 2022 | 35650682 | PubTator, text mining | PubMed |
| Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. | World J Clin Cases | 2022 | 35647163 | PubTator, text mining | PubMed |
| Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy. | Acta Pharm Sin B | 2022 | 35646548 | PubTator, text mining | PubMed |
| A New Risk Model Based on 7 Quercetin-Related Target Genes for Predicting the Prognosis of Patients With Lung Adenocarcinoma. | Front Genet | 2022 | 35646063 | PubTator, text mining | PubMed |
| SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. | J Clin Invest | 2022 | 35642638 | PubTator, text mining | PubMed |
| HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3. | Br J Cancer | 2022 | 35637410 | PubTator, text mining | PubMed |
| LncR-133a Suppresses Myoblast Differentiation by Sponging miR-133a-3p to Activate the FGFR1/ERK1/2 Signaling Pathway in Goats. | Genes (Basel) | 2022 | 35627202 | PubTator, text mining | PubMed |
| Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option. | Cells | 2022 | 35626663 | PubTator, text mining | PubMed |
| Insights into a Cancer-Target Demethylase: Substrate Prediction through Systematic Specificity Analysis for KDM3A. | Biomolecules | 2022 | 35625569 | PubTator, text mining | PubMed |
| Identification of a Potential MiRNA-mRNA Regulatory Network for Osteoporosis by Using Bioinformatics Methods: A Retrospective Study Based on the Gene Expression Omnibus Database. | Front Endocrinol (Lausanne) | 2022 | 35620387 | PubTator, text mining | PubMed |
| Regulation of human T-cell leukemia virus type 1 antisense promoter by myocyte enhancer factor-2C in the context of adult T-cell leukemia and lymphoma. | Haematologica | 2022 | 35615924 | PubTator, text mining | PubMed |
| The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers. | Med Sci Sports Exerc | 2022 | 35611651 | PubTator, text mining | PubMed |
| Rhythm disturbance in osteoarthritis. | Cell Commun Signal | 2022 | 35610652 | PubTator, text mining | PubMed |
| Robust temporal map of human in vitro myelopoiesis using single-cell genomics. | Nat Commun | 2022 | 35610203 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. | MedComm (2020) | 2022 | 35601657 | PubTator, text mining | PubMed |
| The Antifibrotic and the Anticarcinogenic Activity of Capsaicin in Hot Chili Pepper in Relation to Oral Submucous Fibrosis. | Front Pharmacol | 2022 | 35600864 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4205/papers?page=39